MIRA INFORM REPORT

 

 

Report Date :

06.06.2011

 

IDENTIFICATION DETAILS

 

Name :

MEPRO PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

1003, G.I.D.C., Wadhwan, District Surendra Nagar – 363 035, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

31.08.1982

 

 

Com. Reg. No.:

04-005451

 

 

Capital Investment / Paid-up Capital :

Rs.18.000 Millions

 

 

CIN No.:

[Company Identification No.]

U24231GJ1982PTC005451

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHMM05214G

 

 

PAN No.:

[Permanent Account No.]

AABCM4177G

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Pharmaceuticals Formulation and Specialise in Tablets/ Capsules/ Injectables.

 

 

No. of Employees :

250 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 714000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

Profit and loss account for the current year is not available.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

INFORMATION PARTED BY

 

Name :

Mr. Mukesh

Designation :

Company Assistant

Contact No.:

91-2752-241416

Date :

04.06.2011

 

 

LOCATIONS

 

Registered Office/ Factory :

1003, G.I.D.C., Wadhwan, District Surendra Nagar – 363 035, Gujarat, India

Tel. No.:

91-2752-241416

Mobile No. :

91-9920102888 (Mr. Rajesh Shah)

Fax No.:

91-2752-241178

E-Mail :

info@mepropharmaceuticals.com

admin@mepropharmaceuticals.com

dhsejpal44@yahoo.co.in

vkmassociates@yahoo.com

bhavin@mepromax.com

unit_1@mepropharmaceuticals.com

Website :

www.mepropharmaceuticals.com

Area :

4000 sq. ft.

Location :

Owned

 

 

Correspondence Address :

108/109, Dalamal Chambers, New Marine Lanes, Mumbai – 400020, Maharashtra, India

Tel. No.:

91-22-66372777 (4 Lines)

Fax No.:

91-22-66385339

 

 

DIRECTORS

 

As on 30.09.2010

 

Name :

Mr. Vijay Chhabildas Shah

Designation :

Director

Address :

5th Floor, Flat No.501, Panchsheel, Churchgate, C-Road, Marine Drive, Mumbai – 400 020, Maharashtra, India

Date of Birth/Age :

19.02.1945

Date of Appointment :

31.08.1982

DIN No.:

00453308

 

 

Name :

Mr. Rajesh Sumanlal Shah

Designation :

Director

Address :

173, Jolly Maker, Apartment-II, 94, Cuffe Parade, Coloba, Mumbai - 400 005, Maharashtra, India

Date of Birth/Age :

24.06.1961

Date of Appointment :

30.09.1987

DIN No.:

00821466

 

 

Name :

Mr. Bharat Kumar Chhabildas Shah

Designation :

Director

Address :

102, Tareti Apartment, 29/C, Doongarsi Road, Walkeshwar, Mumbai – 400 006, Maharashtra, India

Date of Birth/Age :

07.04.1942

Date of Appointment :

31.08.1982

DIN No.:

00867909

 

 

Name :

Mr. Suresh Chhabildas Shah

Designation :

Director

Address :

5th Floor, Surya Kiron, 551 Pan Gully, Off Huges Road, P.O. 26 WB, Mumbai – 400 036, Maharashtra, India

Date of Birth/Age :

22.02.1947

Date of Appointment :

31.08.1982

DIN No.:

00477470

 

 

Name :

Mr. Prakash Navinchandra Shah

Designation :

Director

Address :

25, Vishne Mahal, 59 - D – Road, Churchgate Reclamation, Mumbai – 400 020, Maharashtra, India

Date of Birth/Age :

22.06.1953

Date of Appointment :

17.07.2004

DIN No.:

00641718

 

 

Name :

Mr. Jaswantlal Shantilal Shah

Designation :

Director

Address :

144, Jain Society, Shanti Niwas, 3rd Floor, Sion (West), Mumbai – 400 022, Maharashtra, India

Date of Birth/Age :

19.11.1936

Date of Appointment :

31.08.1982

DIN No.:

00822700

 

 

Name :

Mr. Mahendra Chhabildas Shah

Designation :

Director

Address :

2301A-2301B, Sterling Tower, Harishchandra Goregaonkar Marg, Gamdevi, Mumbai – 400 007, Maharashtra, India

Date of Birth/Age :

26.07.1934

Date of Ceasing :

01.07.2008

DIN No.:

00668760

 

 

KEY EXECUTIVES

 

Name :

Mr. Mukesh

Designation :

Company Assistant

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2010

 

Names of Shareholders

 

 

No. of Shares

Indumati S. Shah

 

5945

Kaushik N. Shah

 

12200

Prakash N. Shah

 

6268

Rajesh S. Shah

 

9098

Sonal P. Shah

 

6430

Smita S. Shah

 

9057

Sumanlal C. Shah

 

12409

Nainchandra C. Shah

 

330

Kalpana

 

720

Suresh C. Shah

 

18393

Sonal B. Shah

 

6155

Bharat C. Shah

 

10103

Bhavesh B. Shah

 

11192

Sharmistha M. Shah

 

13132

Dharmesh M. Shah

 

14318

Navinchandra C. Shah (HUF)

 

1500

Jayshree V. Shah

 

15287

Vijay C. Shah

 

12163

Jaswant S. Shah

 

3600

Ketan J. Shah

 

1000

Chandra J. Shah

 

1450

Beena K. Shah

 

1450

Ashish D. Shah

 

3330

Mansi K. Shah

 

150

Vinod S. Shah

 

900

Saroj V. Shah

 

420

Kiran D. Shah

 

1620

Snehlata D. Shah

 

600

Ketan J. Shah (HUF)

 

300

Preyas V. Shah

 

480

Total

 

180000

 

As on 30.09.2010

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Pharmaceuticals Formulation and Specialise in Tablets/ Capsules/ Injectables.

 

 

Products :

Item Code No. (ITC Code)

29419001

Product Description

Gatifloaxcin

Item Code No. (ITC Code)

29031200

Product Description

Methylene Chloride

Item Code No. (ITC Code)

Aspirin

Product Description

29182200

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

GENERAL INFORMATION

 

Customers :

Manufacturer

 

 

No. of Employees :

250 (Approximately)

 

 

Bankers :

Bank of India, Bullion Exchange Branch, 185 Sheikh Memon Street, Zaveri Bazar, Mumbai – 400 002, Maharashtra, India

 

 

Facilities :

Secured Loans

31.03.2010

Rs. In Millions

31.03.2009

Rs. In Millions

CASH CREDIT FACILITIES FROM BANK OF INDIA, MUMBAI

(Secured against Hypothecation of Raw Materials, Stock in process Movable Machineries, Stores spares parts, Furniture and all other tangible movable assets wheresoever situated or in transit and personally, guaranteed by all Directors of the Company)

 

 

Bank of India, C/C Hypothecation

0.490

1.719

Total

0.490

1.719

 

Unsecured Loans

31.03.2010

Rs. In Millions

31.03.2009

Rs. In Millions

From Share Holders

0.000

4.279

From Others

1.198

1.134

Total

1.198

5.413

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Dineshkumar V. Shah and Company

Chartered Accountants

Address :

Opposite Peoples Co-Operative Bank, Derasar Road, Wadhwan, Surendra Nagar – 363 001, Gujarat, India

Tel. No.:

91-2752-222144/223446

 

 

CAPITAL STRUCTURE

 

As on 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

200000

Equity Shares

Rs.100/- each

Rs.20.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

180000

Equity Shares

Rs.100/- each

Rs.18.000 Millions

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

18.000

18.000

4.500

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

160.577

150.871

143.460

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

178.577

168.871

147.960

LOAN FUNDS

 

 

 

1] Secured Loans

0.490

1.719

8.604

2] Unsecured Loans

1.198

5.413

25.121

TOTAL BORROWING

1.688

7.132

33.725

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

180.265

176.003

181.685

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

69.520

75.371

80.458

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.002

0.002

0.002

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

43.965
58.796

53.252

 

Sundry Debtors

140.185
122.734

140.585

 

Cash & Bank Balances

21.303
4.186

3.286

 

Other Current Assets

0.000
0.000

0.000

 

Loans, Advances & Deposits

32.907
31.221

30.045

Total Current Assets

238.360

216.937

227.168

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

108.364

93.047

107.828

 

Other Current Liabilities

10.517

16.070

8.602

 

Provisions

8.736
7.190

9.513

Total Current Liabilities

127.617
116.307

125.943

Net Current Assets

110.743
100.630

101.225

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

180.265

176.003

181.685

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Income

 

415.504

409.403

 

 

Other Income

 

7.214

0.415

 

 

TOTAL                                     (A)

 

422.718

409.818

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Raw Material Consumed

 

180.099

178.778

 

 

Trading Purchase

 

24.580

3.897

 

 

Manufacturing and Other Expenses

 

114.397

108.687

 

 

Packing Material Consumed

 

78.938

77.816

 

 

Increase/Decrease in stock

 

(4.159)

1.145

 

 

TOTAL                                     (B)

 

393.855

370.323

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

 

28.863

39.495

 

 

 

 

 

Less

INTEREST                                                         (D)

 

2.497

3.941

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

 

26.366

35.554

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

 

11.426

11.439

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

 

14.940

24.115

 

 

 

 

 

Less

TAX                                                                  (H)

 

5.085

8.197

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

 

9.855

15.918

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

 

128.734

115.328

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Short/Excess Provision of Tax

 

0.339

0.195

 

 

Interim/Proposed Dividend

 

1.800

1.125

 

 

Dividend Tax

 

0.305

0.191

 

 

Transfer to General Reserve

 

1.000

1.000

 

BALANCE CARRIED TO THE B/S

 

135.144

128.734

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

 

3.655

13.516

 

 

Capital Goods

 

1.031

0.365

 

TOTAL IMPORTS

 

4.686

13.881

 

 

 

 

 

 

Earnings Per Share (Rs.)

 

55.00

NA

 

Particulars

 

 

31.03.2011

(Approximately)

31.03.2010

(Approximately)

Sales Turnover

 

450.000

420.000

 

 

 

 

 

Expected Sales (2011-2012): Rs.500.000 millions

 

The above information has been parted by Mr. Mukesh (Company Assistant).

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

NA
2.33

3.88

 

 

 
 

 

Net Profit Margin

(PBT/Sales)

(%)

NA
3.59

5.89

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA
5.11

7.84

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

NA
0.08

0.16

 

 

 
 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.72
0.73

1.07

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

1.87
1.86

1.80

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Details of Sundry Creditors:

 

Particulars

 

31.03.2010

(Rs. in millions)

31.03.2009

(Rs. in millions)

31.03.2008

(Rs. in millions)

Sundry Creditors

87.848

76.118

99.178

Sundry Creditors (Expenses)

20.516

16.929

8.650

 

108.364

93.047

107.828

 

FINANCIAL RESULTS:

 

After meeting all the expenses, the accounts for the period shows a Profit Rs.148.002 millions.

 

FORM 8

 

Corporate identity number of the company

U24231GJ1982PTC005451

Name of the company

MEPRO PHARMACEUTICALS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Surendra Nagar, Gujarat, India

This form is for

Creation of charge

Type of charge

Equitable mortgage or mortgage of property by depositing the title deeds

Particular of charge holder

Bank of India, Bullion Exchange Branch, 185 Sheikh Memon Street, Zaveri Bazar, Mumbai – 400 002, Maharashtra, India

E-Mail: boibulliobr@vsnl.net

Nature of instrument creating charge

Oral Assent

Date of instrument Creating the charge

14.08.2006

Amount secured by the charge

Rs.37.000 millions

Brief of the principal terms an conditions and extent and operation of the charge

Working capital limits :

(1) Cash credit hypothecation of stocks: Rs.15.000 millions; (2) Cash credit hypothecation of book debts: Rs.25.000 millions; (3) FBP/FBN: Rs.10.000 millions; Max. (1+2+3): Rs.35.000 millions; (4) L/C (I/F) DP/DA 90 days: (Rs.9.000 millions).

Non-fund based limits: Inland guarantee: Rs.2.000 millions.

Aggregate limit: Rs.37.000 millions.

Date of instrument creating or evidencing the charge

14.08.2006

Description of the instrument creating or evidencing the charge

Oral Assent

Date of acquisition of the property

25.07.2006

Amount owing on security of the charge

Rs.37.000 millions

Particulars of the property charged

Equitable mortgage by deposit of title deeds with the bank of the company's immovable properties being all that piece and parcel of land, building thereon and plant and machinery at  Plot Nos.1001/B, 1003, 1412, 1311-1312, 1413-1310,  GIDC, Wadhwan Area Within The Village Limits of Wadhwan admeasuring 11692.80 sq. mtrs.

Description of the property charged indicating whether it is a charged on

Immovable properties

Particulars of the property charged

Equitable mortgage by deposit of title deeds with the bank of the company's immovable properties being all that piece and parcel of land, building thereon and plant and machinery at  Plot Nos.1001/B, 1003, 1412, 1311-1312, 1413-1310,  GIDC, Wadhwan Area Within The Village Limits of Wadhwan admeasuring 11692.80 sq. mtrs.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate identity number of the company

U24231GJ1982PTC005451

Name of the company

MEPRO PHARMACEUTICALS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

1003, G.I.D.C., Wadhwan – 363 035, District Surendra Nagar, Gujarat, India

This form is for

Creation of charge

Type of charge

Hypothecation

Particular of charge holder

Bank of India, Bullion Exchange Branch, 185 Sheikh Memon Street, Zaveri Bazar, Mumbai – 400 002, Maharashtra, India

Email :- boibulliobr@vsnl.net

Nature of instrument creating charge

Charge and hypothecation of book debts.

Date of instrument Creating the charge

25.07.2006

Amount secured by the charge

Rs.25.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Interest at the rate of 1.25% below bank rate with a minimum of 10% p. a. with monthly rests or at such other rate as may be fixed by the bank from time to time for the cash credit hypothecation of book debts limit of Rs.25.000 millions granted by the bank to the company.

Description of the property charged indicating whether it is a charged on

Book Debts

Particulars of the property charged

The borrower hypothecates and charges to the bank all the book debts outstandings, moneys receivable, claims and bills which are now due and owing or which may at any time hereafter during the continuance of this security become due and owing to the borrower in the course of its business by any person, company or by the government or any local or public body or authority.

 

FIXED ASSETS:

 

v      Leasehold Land

v      Building

v      Plant and Machinery

v      Utility

v      Research and Development Equipment

v      Electricity and Fittings

v      Furniture and Fitting

v      Computer

v      Office Equipment

v      Motor Car

v      Office Premises

v      Employees Residential Quarter

v      Office Building

v      Pollution Control Equipment

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.44.85

UK Pound

1

Rs.73.29

Euro

1

Rs.64.89

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.